viernes, 7 de abril de 2017

Ivanhoe's Top 5 Reports This Week


April 7, 2017

CAR T Therapy (2nd Week)

TAMPA, Fla. (Ivanhoe Newswire) — A new form of immunotherapy is being called a milestone in cancer treatment. Could this be the big break patients have been waiting for?

ST. LOUIS, Mo. (Ivanhoe Newswire) — About 75 percent of all Americans will experience back pain at some point in their lives; for those with serious, chronic pain, finding relief can be a challenge. A new implantable device is bringing quick relief to patients who have exhausted other options.

ORLANDO, Fla. (Ivanhoe Newswire) — The American Cancer Society now reports that your chances of getting cancer are one in two for men and one in three for women. Those are horrible odds, but doctors say 50 percent of all cancer deaths could’ve been prevented by changes in lifestyle and diet. Here are some popular foods that you should just stay away from.

TAMPA, Fla. (Ivanhoe Newswire) — Breast cancer is the second most common cancer in American women. More than 300,000 women will be diagnosed this year. Researchers are working on a vaccine that could lead to prevention.

ST. LOUIS, Mo. (Ivanhoe Newswire) — Over one million Americans are living with HIV, and one in eight doesn’t know they are infected. There is no cure, but there are almost 30 drugs that people can take to help them stay healthy, and now there is one FDA-approved drug that people at risk for HIV can take to prevent them from becoming infected.

Give the gift of health news!
Click here to sign up your friends and loved ones for the 

First to Know Newsletter!

Smart Living for this week:


Little Girls Don’t Think Women Are Brilliant​

Body Language

Perfect Packing For Travel


Doctor's In-depth Interview of the week
Tumor Paint for Hunter’s Brain - In-Depth Doctor Interview​


Quote of the week:

The secret of change is to focus all of your energy not on fighting the old, but on building the new.” 

— Dan Millman, Way of the Peaceful Warrior


Website Information:

Content Licensing:


No hay comentarios:

Publicar un comentario